Search

You searched for "hospital"

416 results found

REPORT: Urology News Patient Engagement Evenings

6 November 2020
Towards the end of 2019 the team at Urology News began making plans for our first event. An educational study day focusing on how to improve patient engagement in urology was to be held in Edinburgh at the end of...

Purple urine bag syndrome

1 July 2021 | | URO - Infection, URO - Functional / Reconstructive Urology, URO - Trauma & Emergency
Purple urine bag syndrome (PUBS) is an uncommon phenomenon where the tubing and urinary catheter bag is noticed to undergo purple discolouration. This has been linked with urinary tract infections (UTI), chronic debilitated states and prolonged catheterisation. PUBS was noticed...

Help to handle increased volumes of urethral catheterisations safely

22 April 2020 | Contracts & Distributors
With urethral catheterisation volumes currently considerably increased, we are pleased to be able to announce that NHS Supply Chain is now listing the...

BBS Revolution™ Bladder Scanner

16 August 2021 | Research & Development
Featuring a wireless scanning probe with eight ultrasound transducers for fully automatic bladder detection, BBS Revolution™ differentiates between male/female anatomy, delivering accurate measurements in seconds.

Children’s bowel and bladder health takes centre stage in World Continence Week

26 June 2025
World Continence Week (16–22 June in 2025) is an annual global awareness campaign that shines a spotlight on bowel and bladder issues. This year, the focus was on children, as ERIC, The Children’s Bowel and Bladder Charity brought the issue...

Dogs and humans share a bladder cancer biomarker: a new discovery that opens doors for early detection and treatment

9 September 2025
A new scientific study has identified a new molecular biomarker that could help doctors detect aggressive early-stage bladder cancer, such as high-grade non-muscle invasive bladder cancer (NMIBC), in both dogs and humans. This discovery advances our knowledge of how aggressive...

DUS Annual Meeting 2025 – a story from Nyborg Strand

1 May 2026 | Urology News
13–15 November 2025 / Funen, Denmark Naomi Nadler, Urology Resident; Rose Laursen, Urology Resident; and Stine Hedegaard, Consultant Urologist, Department of Urology, Zealand University Hospital, Roskilde, Denmark. Every November, the urological community of Denmark migrates to the central island Funen...

MPs urge government to end continence pad ‘rationing’ after trusts found limiting supplies

19 June 2026 | Urology News
A group of MPs have called on the government to intervene over what they describe as the “rationing” of continence products across the NHS, warning that thousands of patients are being left without adequate support and may be costing the...

Penile cancer: a practical approach

6 November 2020 | | URO - Urologic Oncology
Penile cancer is rare and accounts for less than 1% of all new cancer cases in males in the UK, with around 640 new cases diagnosed every year [1]. In England and Wales, the annual incidence is between 1.2 and...

Management of RHC in prostate cancer with selective embolisation and hyperbaric oxygen therapy

4 July 2024 | | URO - Urologic Oncology
Prostate cancer is one of the most prevalent malignancies affecting men worldwide. Radiotherapy is a common treatment modality for localised and locally advanced prostate cancer. While radiotherapy can be effective, it may lead to complications such as radiation-induced haemorrhagic cystitis...

Assessment and management of percutaneous nephrostomies

8 January 2024 | | URO - Trauma & Emergency, URO - Uroradiology
Nephrostomies are a valuable uroradiological intervention which enables drainage of the obstructed kidney, amongst other indications. Complications associated with nephrostomies following placement are not uncommon, with re-presentation to the emergency department or surgical emergency unit. In this review we will...

Testing radical prostatectomy in men with prostate cancer and oligometastases to the bone: a randomised controlled feasibility study

1 May 2017 | | URO - Urologic Oncology
Prostate cancer is the commonest cancer and the second most frequent cause of cancer death in Western men [1]. The recent STAMPEDE data suggests a median survival of just 42.1 months in the control arm of metastatic men [2]. Current...